Cargando…
Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art
We explain the state of the art of the immunohistochemical markers of response in rectal cancers treated with neoadjuvant medical therapies and its implication with prognosis. Neoadjuvant chemoradiotherapy is widely used to improve the outcome of patients with locally advanced rectal cancer, and the...
Autores principales: | Del Gobbo, Alessandro, Ferrero, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343286/ https://www.ncbi.nlm.nih.gov/pubmed/28326100 http://dx.doi.org/10.1155/2017/2808235 |
Ejemplares similares
-
Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma
por: Lopez, Gianluca, et al.
Publicado: (2018) -
Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis
por: Huh, Jung Wook, et al.
Publicado: (2015) -
Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.
por: Allen, D. C., et al.
Publicado: (1999) -
Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer
por: Taha, Anas, et al.
Publicado: (2022) -
Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)